Item 9 Labs Corp. (INLB) Financials

INLB Assets vs Liabilities
DateAssetsLiabilities
June 30, 2023 112.0 million 59.4 million
March 31, 2023 114.1 million 56.4 million
Dec. 31, 2022 114.7 million 54.3 million
Sept. 30, 2022 110.8 million 48.8 million

INLB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2023 87292 860332
March 31, 2023 304082 459460
Dec. 31, 2022 -1.3 million 1.1 million
Sept. 30, 2022 -1.6 million 464575

INLB Net Income

No data available :(

INLB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2023 183429 - 392453
March 31, 2023 101150 - 937280
Dec. 31, 2022 21781 - 702203
Sept. 30, 2022 85637 7.2 million 954325

INLB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2023 101.8 million
March 31, 2023 101.1 million
Dec. 31, 2022 99.2 million
Sept. 30, 2022 97.7 million

INLB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2023 62845 - 3.4 million 322193
March 31, 2023 1494 - 3.7 million 385022
Dec. 31, 2022 6825 - 3.3 million 287949
Sept. 30, 2022 1.4 million - 7.5 million 551430

INLB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2023 5.0 million 2.2 million
March 31, 2023 5.7 million 1.9 million
Dec. 31, 2022 5.0 million 2.4 million
Sept. 30, 2022 4.0 million 3.4 million

INLB Revenue by Segment
Graph available only for paid members. Upgrade to see it.

INLB

Price: $0

52 week price:
0.00
0.00

Earnings Per Share: -0.33 USD

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 70181

Links: